Summary

• Page properties (1 modified, 0 added, 0 removed)

Details

Page properties

Content

...	...	@@ -22,9 +22,23 @@
22	22	Natco family currently consists of around 5000 employees, Natco Pharma is consistently ranked among fastest growing pharmaceutical companies in India. Natco is well recognized for its innovation in Pharmaceutical R&D.
23	23
24	24
25		-.
	25	+== Milestone ==
26	26
	27	+|1981|Incorporated Natco Pharma Division at Kothur,  Mahaboobnagar Dist, Telangana, India
	28	+|1984|First Full year in operationss - sales of Rs. 0.5 million
	29	+|1986|Inaugurated parentals manufacturing facility at Nagarjunasagar, Telangana, India
	30	+|1993|Inaugurated NATCO's chemical division at Mekaguda in Telangana
	31	+|1997|Inaugurated Natco Research Center (NRC) at Sanathnagar, Hyderabad, India
	32	+|2003|Launched Oncology division with introduction of flagship brand VEENAT (generic Imatinib Mesylate) for the treatment of chronic myelogenous leukemia.
	33	+|2006|Incorporated a finished dosage facility at Dehradun, Uttarakhand.
	34	+|2007|Natco launched its first ever ANDA in the US Market. Natco acquired Savemart Pharmacy in USA.
	35	+|2011|Incorporated NATCOfarma do Brazil LTDA
	36	+|2013|Established Natco Pharma Canada Inc for sales &  distribution in Canada.
	37	+|2014|Established Natco Pharma Australia Pty Ltd for sales & distribution in Australia.
	38	+|2019|Commercial manufacturing operations begin in NATCO's Visakhapatnam Formulation Facility. NATCO launches Crop Health Sciences Division.
	39	+|2020|NATCO's Visakhapatnam Formulation Facility receives USFDA approval. NATCO supplies Chloroquine Phosphate tablets to the US market in support Of COVID-19 treatment.
27	27
	41	+
28	28	== Products ==
29	29
30	30	* Glatiramer Acetate
...	...	@@ -35,7 +35,6 @@
35	35	* Geftinat
36	36	* Veenat (Imatinib)
37	37
38		-
39	39	[[image:NATCOPHARM1.png]]
40	40
41	41
...	...	@@ -74,7 +74,6 @@
74	74
75	75	* Formulation Plant Attivaram
76	76
77		-
78	78	[[image:NATCOPHARM3.jpg]]
79	79
80	80